|By Business Wire||
|June 25, 2014 11:00 AM EDT||
Omicia, Inc., a leading clinical genomics company, today announced it has expanded its scientific advisory board (SAB). Four new world-renowned clinical and genomic scientists will advise the strategic development of Omicia’s clinical diagnostic genome interpretation software, and support the company’s vision of improved patient care through personalized medicine.
Omicia combines genome science with state-of-the-art engineering to help researchers and clinical diagnostic organizations analyze and identify the genetic basis of a variety of conditions, including childhood disease, cancer and cardiovascular disease.
“Genomics is advancing swiftly from the research lab to the clinic,” said Martin Reese, Omicia’s Founder and President, “so we are thrilled to expand our scientific advisory board to provide clinical expertise to the nascent world of patient-centric individualized medicine. Having some of the best minds in genomic medicine ensures that our products have scientific merit, are evidence-based, and where applicable, provide actionable value to clinicians. We are extremely honored to have such a superb and extinguished SAB and thank our members for their trust and commitment.”
The new members of Omicia’s SAB represent expertise in both clinical and research aspects of genomics:
- Heidi Rehm, Ph.D., FACMG – One of the Principal Investigators of a recent NIH-funded initiative called the “Clinical Genome Resource” (ClinGen); Director of the Laboratory for Molecular Medicine at Partners Healthcare Personalized Medicine and Associate Professor of Pathology at Harvard Medical School.
- Geoffrey Ginsburg, M.D., Ph.D. – Pioneer in translational genomics and precision medicine with funding from the NIH, the US Air Force, the US Navy, DARPA and the Gates Foundation; Director, Genomic Medicine of the Duke Institute for Genome Sciences & Policy; and Executive Director of the Center for Personalized Medicine and Precision, Duke Medicine and Professor of Medicine and Biomedical Engineering.
- Thomas Quertermous, M.D. – A renowned expert whose research focuses on the genetic basis of cardiovascular disease; William G. Irwin Professor of Medicine and Director of Research for the Division of Cardiovascular Medicine at Stanford University; senior author of recently-published JAMA paper on the current state of whole genome sequencing, interpretation and clinical practicality.
- Mark Yandell, Ph.D. – Internationally recognized expert in comparative genomics and bioinformatics with roots in the early days of the Human Genome Project at Washington University and Celera Genomics; University of Utah H.A. & Edna Benning Presidential Endowed Chair Professor of Human Genetics, and Co-director of the USTAR Center for Genetic Discovery; collaborator and co-inventor of Omicia’s VAAST and newly-released Phevor algorithms.
“The genetic community is facing the challenge of bringing genomic insights into clinical practice,” said Heidi Rehm. “Novel genomic and bioinformatics algorithmic approaches, combined with solid software engineering skills, are key to meeting that challenge.” Geoffrey Ginsburg added, “The time is right for genomics to become part of clinical medicine. I applaud Omicia’s scientific approach of unique algorithms rooted in a deep understanding of molecular biology and biomedical ontologies, supported by a series of NIH grants and fundamental publications.”
“As a long-time collaborator with Omicia, I look forward to joining Martin Reese and the other members of Omicia’s SAB to bring novel methods and tools in genomic medicine to market through solid and thoughtful software engineering and marketing approaches,” said Mark Yandell. “The VAAST tool developed at the University of Utah is now accessible to researchers and clinicians anywhere in the world through Omicia’s user-friendly Opal application. Over the last few years it has advanced from research prototype to robust and validated clinical tool.” Thomas Quertermous added, “I am honored to lend my expertise and medical experience to the Omicia team to guide them as they build a robust decision-making system for clinical care organizations. Omicia is uniquely positioned with its powerful algorithms and team of experts to become a leader in the emerging world of clinical genomics.”
The new scientific advisory board members join current members Paul Billings, M.D., Ph.D., Paul Flicek, Ph.D., Leroy Hood, M.D., Ph.D., Pui-Yan Kwok, M.D., Ph.D., James Scott, M.D., Ph.D., and John Witte, Ph.D.
About Omicia, Inc.
Omicia delivers genome analysis solutions for research, diagnostic and clinical applications. Our market-leading clinical bioinformatics software platform enables analysis, interpretation and reporting on genomic data to expedite diagnosis and improve medical outcomes. Omicia’s products are in use at more than 300 world-class academic and clinical institutions worldwide. By accelerating understanding of the genetic basis of disease, drug response and health, Omicia is unlocking the potential of individualized medicine. Headquartered in Oakland, California, Omicia was founded by renowned industry veterans with a deep understanding of technology, genomics and diagnostics. Investors include Artis Ventures, Acadia Woods, Bay City Capital, Buchanan Investments, Casdin Capital and Yuri Milner. For more information, visit www.omicia.com and follow us on Twitter @omicia.
Most technology leaders, contemporary and from the hardware era, are reshaping their businesses to do software in the hope of capturing value in IoT. Although IoT is relatively new in the market, it has already gone through many promotional terms such as IoE, IoX, SDX, Edge/Fog, Mist Compute, etc. Ultimately, irrespective of the name, it is about deriving value from independent software assets participating in an ecosystem as one comprehensive solution.
Apr. 26, 2017 10:00 AM EDT Reads: 410
SYS-CON Events announced today that Hitachi Data Systems, a wholly owned subsidiary of Hitachi LTD., will exhibit at SYS-CON's 20th International Cloud Expo®, which will take place on June 6-8, 2017, at the Javits Center in New York City. Hitachi Data Systems (HDS) will be featuring the Hitachi Content Platform (HCP) portfolio. This is the industry’s only offering that allows organizations to bring together object storage, file sync and share, cloud storage gateways, and sophisticated search an...
Apr. 26, 2017 10:00 AM EDT Reads: 467
SYS-CON Events announced today that Hitachi, the leading provider the Internet of Things and Digital Transformation, will exhibit at SYS-CON's 20th International Cloud Expo®, which will take place on June 6-8, 2017, at the Javits Center in New York City, NY. Hitachi Data Systems, a wholly owned subsidiary of Hitachi, Ltd., offers an integrated portfolio of services and solutions that enable digital transformation through enhanced data management, governance, mobility and analytics. We help globa...
Apr. 26, 2017 09:45 AM EDT Reads: 2,314
Blockchain is a shared, secure record of exchange that establishes trust, accountability and transparency across supply chain networks. Supported by the Linux Foundation's open source, open-standards based Hyperledger Project, Blockchain has the potential to improve regulatory compliance, reduce cost and time for product recall as well as advance trade. Are you curious about Blockchain and how it can provide you with new opportunities for innovation and growth? In her session at 20th Cloud Exp...
Apr. 26, 2017 09:45 AM EDT Reads: 1,859
Cloud promises the agility required by today’s digital businesses. As organizations adopt cloud based infrastructures and services, their IT resources become increasingly dynamic and hybrid in nature. Managing these require modern IT operations and tools. In his session at 20th Cloud Expo, Raj Sundaram, Senior Principal Product Manager at CA Technologies, will discuss how to modernize your IT operations in order to proactively manage your hybrid cloud and IT environments. He will be sharing be...
Apr. 26, 2017 09:26 AM EDT Reads: 207
In his keynote at 19th Cloud Expo, Sheng Liang, co-founder and CEO of Rancher Labs, discussed the technological advances and new business opportunities created by the rapid adoption of containers. With the success of Amazon Web Services (AWS) and various open source technologies used to build private clouds, cloud computing has become an essential component of IT strategy. However, users continue to face challenges in implementing clouds, as older technologies evolve and newer ones like Docker c...
Apr. 26, 2017 09:00 AM EDT Reads: 285
Quickly find the root cause of complex database problems slowing down your applications. Up to 88% of all application performance issues are related to the database. DPA’s unique response time analysis shows you exactly what needs fixing - in four clicks or less. Optimize performance anywhere. Database Performance Analyzer monitors on-premises, on VMware®, and in the Cloud, including Amazon® AWS and Azure™ virtual machines.
Apr. 26, 2017 08:45 AM EDT Reads: 1,903
Apr. 26, 2017 08:45 AM EDT Reads: 143
Five years ago development was seen as a dead-end career, now it’s anything but – with an explosion in mobile and IoT initiatives increasing the demand for skilled engineers. But apart from having a ready supply of great coders, what constitutes true ‘DevOps Royalty’? It’ll be the ability to craft resilient architectures, supportability, security everywhere across the software lifecycle. In his keynote at @DevOpsSummit at 20th Cloud Expo, Jeffrey Scheaffer, GM and SVP, Continuous Delivery Busine...
Apr. 26, 2017 07:45 AM EDT Reads: 743
Did you know that you can develop for mainframes in Java? Or that the testing and deployment can be automated across mobile to mainframe? In his session at @DevOpsSummit at 20th Cloud Expo, Vaughn Marshall, Sr. Principal Product Owner at CA Technologies, will discuss and demo how increasingly teams are developing with agile methodologies using modern development environments and automating testing and deployments, mobile to mainframe.
Apr. 26, 2017 07:45 AM EDT Reads: 1,273
The goal of Continuous Testing is to shift testing left to find defects earlier and release software faster. This can be achieved by integrating a set of open source functional and performance testing tools in the early stages of your software delivery lifecycle. There is one process that binds all application delivery stages together into one well-orchestrated machine: Continuous Testing. Continuous Testing is the conveyor belt between the Software Factory and production stages. Artifacts are ...
Apr. 26, 2017 07:45 AM EDT Reads: 1,163
DevOps is often described as a combination of technology and culture. Without both, DevOps isn't complete. However, applying the culture to outdated technology is a recipe for disaster; as response times grow and connections between teams are delayed by technology, the culture will die. A Nutanix Enterprise Cloud has many benefits that provide the needed base for a true DevOps paradigm. In his Day 3 Keynote at 20th Cloud Expo, Chris Brown, a Solutions Marketing Manager at Nutanix, will explore t...
Apr. 26, 2017 07:45 AM EDT Reads: 657
Apr. 26, 2017 07:30 AM EDT Reads: 8,909
DevOps is often described as a combination of technology and culture. Without both, DevOps isn't complete. However, applying the culture to outdated technology is a recipe for disaster; as response times grow and connections between teams are delayed by technology, the culture will die. A Nutanix Enterprise Cloud has many benefits that provide the needed base for a true DevOps paradigm.
Apr. 26, 2017 07:00 AM EDT Reads: 827
SYS-CON Events announced today that CollabNet, a global leader in enterprise software development, release automation and DevOps solutions, will be a Bronze Sponsor of SYS-CON's 20th International Cloud Expo®, taking place from June 6-8, 2017, at the Javits Center in New York City, NY. CollabNet offers a broad range of solutions with the mission of helping modern organizations deliver quality software at speed. The company’s latest innovation, the DevOps Lifecycle Manager (DLM), supports Value S...
Apr. 26, 2017 06:00 AM EDT Reads: 808